Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials

Affiliations

• ¹ Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. [email protected].
• ² Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel. [email protected].
• ³ Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
• ⁴ Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.
• ⁵ Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Pembroke Pines, FL, USA.
• ⁶ Albert Einstein College of Medicine, New York, NY, USA.
• ⁷ Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
• ⁸ Case Western Reserve University School of Medicine, Cleveland, OH, USA.
• ⁹ Indiana University Simon Cancer Center, Indianapolis, IN, USA.
• ¹⁰ Department of Hematology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
• ¹¹ Cancer Research Foundation, Chappaqua, NY, USA.
• ¹² Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ¹³ Division of Hematology, Mayo Clinic, Rochester, MN, USA.